BRCA to the future: How testing old ovarian tissue samples could save lives

Tissue samples from 1500 women diagnosed with ovarian cancer in the past 15 years will be retrospectively tested in a bid to prevent cancers caused by the BRCA1 and BRCA2 mutations.

The four-year Traceback program will use the results to identify carriers, notify family members, and then offer testing to women at risk, allowing them to consider taking preventive action.

The Peter MacCallum